NCI-H211 Cells
USUSD$700.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | NCI-H211 is a human lung carcinoma cell line classified as non-small cell lung cancer (NSCLC). It was derived from an adult patient and is part of the panel of thoracic malignancy models developed through the NCI-Navy Medical Oncology Branch. The cell line demonstrates epithelial morphology and adherent growth behavior in vitro, making it suitable for monolayer culture systems. It is typically maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum and incubated under standard conditions (37°C, 5% CO₂). On a molecular level, NCI-H211 harbors mutations consistent with NSCLC pathogenesis. Specifically, it possesses an activating KRAS mutation, a hallmark of a subset of lung adenocarcinomas that drives oncogenic signaling through the MAPK and PI3K/AKT pathways. This mutation contributes to the cell line's resistance to certain targeted therapies, particularly EGFR inhibitors, while simultaneously rendering it a useful model for studying KRAS-directed therapeutic strategies. Protein-level profiling studies, such as those using reverse-phase protein arrays (RPPA), have identified NCI-H211 among the KRAS-mutant lung cancer models with specific signaling dependencies, aiding in the identification of biomarkers and therapeutic targets. NCI-H211 has been featured in large-scale proteomic and pharmacologic screens and has been used to evaluate drug sensitivities and protein expression patterns. These features make it an effective model for translational research focused on developing treatment approaches for KRAS-driven NSCLC and investigating resistance mechanisms associated with targeted and cytotoxic agents. |
|---|---|
| 生物體 | Human |
| 組織 | Metastatic |
| 疾病 | Lung small cell carcinoma |
| 同義詞 | H211, H-211, NCIH211 |
特徵
| 年齡 | 50 years |
|---|---|
| 性別 | Female |
| 族裔 | Caucasian |
| 生長特性 | Aggregates in suspension |
監管數據
| 引用 | NCI-H211 (Cytion catalog number 305837) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_1529 |
生物分子資料
| 突變譜 | Mutation: TP53, Simple, p.Arg248Gln (c.743G>A), Unspecified (PubMed=1312696, PubMed=1565469) |
|---|---|
| 核型分析 | Iso(3p), t(3;4)(pter-q12), t(3;11)(qter-p25) |
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | None |
| 播種密度 | 0.1 to 1 x 106 cells/ml |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305837-060226 | 分析證明書 | 05. Mar. 2026 | 305837 |
-
Related products
Related products